nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HTR3A—fourth ventricle—brain cancer	0.0291	0.0598	CbGeAlD
Amoxapine—HTR1B—dura mater—brain cancer	0.0284	0.0583	CbGeAlD
Amoxapine—HTR2C—choroid plexus—brain cancer	0.0232	0.0475	CbGeAlD
Amoxapine—HTR1B—trigeminal nerve—brain cancer	0.0122	0.0251	CbGeAlD
Amoxapine—DRD3—telencephalic ventricle—brain cancer	0.0122	0.025	CbGeAlD
Amoxapine—CYP2D6—Lomustine—brain cancer	0.0117	0.569	CbGbCtD
Amoxapine—HTR2A—choroid plexus—brain cancer	0.0116	0.0238	CbGeAlD
Amoxapine—HTR3A—cranial nerve—brain cancer	0.0104	0.0213	CbGeAlD
Amoxapine—HRH1—nose—brain cancer	0.00896	0.0184	CbGeAlD
Amoxapine—CYP2D6—Hydroxyurea—brain cancer	0.0089	0.431	CbGbCtD
Amoxapine—DRD1—telencephalic ventricle—brain cancer	0.00874	0.0179	CbGeAlD
Amoxapine—HTR1B—cranial nerve—brain cancer	0.0087	0.0179	CbGeAlD
Amoxapine—HTR7—vein—brain cancer	0.00851	0.0175	CbGeAlD
Amoxapine—HTR6—ganglion—brain cancer	0.00731	0.015	CbGeAlD
Amoxapine—HTR1B—telencephalic ventricle—brain cancer	0.00708	0.0145	CbGeAlD
Amoxapine—SLC6A3—telencephalic ventricle—brain cancer	0.00702	0.0144	CbGeAlD
Amoxapine—HTR2C—telencephalic ventricle—brain cancer	0.00679	0.0139	CbGeAlD
Amoxapine—HTR7—cranial nerve—brain cancer	0.00671	0.0138	CbGeAlD
Amoxapine—HTR7—pons—brain cancer	0.00663	0.0136	CbGeAlD
Amoxapine—Disorientation—Lomustine—brain cancer	0.00621	0.018	CcSEcCtD
Amoxapine—Tongue discolouration—Temozolomide—brain cancer	0.00608	0.0176	CcSEcCtD
Amoxapine—Petechiae—Procarbazine—brain cancer	0.0059	0.0171	CcSEcCtD
Amoxapine—HTR2A—trigeminal nerve—brain cancer	0.00588	0.0121	CbGeAlD
Amoxapine—HTR2A—cerebellar cortex—brain cancer	0.00585	0.012	CbGeAlD
Amoxapine—HTR1A—telencephalic ventricle—brain cancer	0.00571	0.0117	CbGeAlD
Amoxapine—HTR7—telencephalic ventricle—brain cancer	0.00546	0.0112	CbGeAlD
Amoxapine—DRD1—ganglion—brain cancer	0.00544	0.0112	CbGeAlD
Amoxapine—Desloratadine—CYP2C9—brain cancer	0.00533	0.509	CrCbGaD
Amoxapine—HTR2A—vein—brain cancer	0.00531	0.0109	CbGeAlD
Amoxapine—HTR3A—ganglion—brain cancer	0.00525	0.0108	CbGeAlD
Amoxapine—Ataxia—Lomustine—brain cancer	0.00522	0.0152	CcSEcCtD
Amoxapine—DRD2—telencephalic ventricle—brain cancer	0.00516	0.0106	CbGeAlD
Amoxapine—Cerebration impaired—Temozolomide—brain cancer	0.00499	0.0145	CcSEcCtD
Amoxapine—Nightmare—Procarbazine—brain cancer	0.00469	0.0136	CcSEcCtD
Amoxapine—HTR1B—ganglion—brain cancer	0.00441	0.00904	CbGeAlD
Amoxapine—SLC6A3—ganglion—brain cancer	0.00437	0.00897	CbGeAlD
Amoxapine—Gynaecomastia—Procarbazine—brain cancer	0.00435	0.0126	CcSEcCtD
Amoxapine—HTR2C—ganglion—brain cancer	0.00422	0.00867	CbGeAlD
Amoxapine—HTR2A—cranial nerve—brain cancer	0.00419	0.00859	CbGeAlD
Amoxapine—Stomatitis—Lomustine—brain cancer	0.00417	0.0121	CcSEcCtD
Amoxapine—HTR2A—pons—brain cancer	0.00414	0.00849	CbGeAlD
Amoxapine—SLC6A4—ganglion—brain cancer	0.004	0.00822	CbGeAlD
Amoxapine—Disorientation—Procarbazine—brain cancer	0.00394	0.0114	CcSEcCtD
Amoxapine—Vascular purpura—Procarbazine—brain cancer	0.00394	0.0114	CcSEcCtD
Amoxapine—Extrapyramidal disorder—Temozolomide—brain cancer	0.0039	0.0113	CcSEcCtD
Amoxapine—Purpura—Procarbazine—brain cancer	0.00366	0.0106	CcSEcCtD
Amoxapine—Petechiae—Temozolomide—brain cancer	0.00357	0.0104	CcSEcCtD
Amoxapine—HTR1A—ganglion—brain cancer	0.00356	0.0073	CbGeAlD
Amoxapine—SLC6A2—ganglion—brain cancer	0.00353	0.00724	CbGeAlD
Amoxapine—HTR1B—blood vessel—brain cancer	0.0035	0.00719	CbGeAlD
Amoxapine—HTR2A—telencephalic ventricle—brain cancer	0.0034	0.00699	CbGeAlD
Amoxapine—HTR7—ganglion—brain cancer	0.0034	0.00697	CbGeAlD
Amoxapine—Alopecia—Lomustine—brain cancer	0.0034	0.00986	CcSEcCtD
Amoxapine—Disturbance in attention—Temozolomide—brain cancer	0.00339	0.00984	CcSEcCtD
Amoxapine—GABRA1—hindbrain—brain cancer	0.00334	0.00686	CbGeAlD
Amoxapine—Ataxia—Procarbazine—brain cancer	0.00332	0.00963	CcSEcCtD
Amoxapine—SLC6A3—hindbrain—brain cancer	0.00331	0.0068	CbGeAlD
Amoxapine—DRD2—ganglion—brain cancer	0.00321	0.00659	CbGeAlD
Amoxapine—Coordination abnormal—Carmustine—brain cancer	0.00309	0.00899	CcSEcCtD
Amoxapine—Disorientation—Hydroxyurea—brain cancer	0.00305	0.00886	CcSEcCtD
Amoxapine—SLC6A4—hindbrain—brain cancer	0.00304	0.00623	CbGeAlD
Amoxapine—Eosinophilia—Procarbazine—brain cancer	0.00302	0.00876	CcSEcCtD
Amoxapine—Leukopenia—Lomustine—brain cancer	0.00299	0.00869	CcSEcCtD
Amoxapine—Coordination abnormal—Temozolomide—brain cancer	0.00299	0.00868	CcSEcCtD
Amoxapine—Pancreatitis—Procarbazine—brain cancer	0.00299	0.00868	CcSEcCtD
Amoxapine—HTR2A—pineal body—brain cancer	0.00295	0.00606	CbGeAlD
Amoxapine—HTR7—endothelium—brain cancer	0.00293	0.00601	CbGeAlD
Amoxapine—Tingling sensation—Etoposide—brain cancer	0.00292	0.00849	CcSEcCtD
Amoxapine—Numbness—Etoposide—brain cancer	0.00283	0.00823	CcSEcCtD
Amoxapine—HTR6—telencephalon—brain cancer	0.00282	0.00579	CbGeAlD
Amoxapine—Pollakiuria—Procarbazine—brain cancer	0.00282	0.00818	CcSEcCtD
Amoxapine—Gynaecomastia—Carmustine—brain cancer	0.00272	0.0079	CcSEcCtD
Amoxapine—Drowsiness—Procarbazine—brain cancer	0.00272	0.00789	CcSEcCtD
Amoxapine—Sensory loss—Etoposide—brain cancer	0.00271	0.00788	CcSEcCtD
Amoxapine—HTR7—blood vessel—brain cancer	0.0027	0.00555	CbGeAlD
Amoxapine—HTR1A—hindbrain—brain cancer	0.0027	0.00553	CbGeAlD
Amoxapine—Thrombocytopenia—Lomustine—brain cancer	0.00267	0.00776	CcSEcCtD
Amoxapine—Stomatitis—Procarbazine—brain cancer	0.00265	0.00769	CcSEcCtD
Amoxapine—Jaundice—Procarbazine—brain cancer	0.00265	0.00769	CcSEcCtD
Amoxapine—Mental disability—Carmustine—brain cancer	0.00264	0.00766	CcSEcCtD
Amoxapine—Anorexia—Lomustine—brain cancer	0.0026	0.00756	CcSEcCtD
Amoxapine—HTR7—hindbrain—brain cancer	0.00258	0.00529	CbGeAlD
Amoxapine—Mental disability—Temozolomide—brain cancer	0.00255	0.0074	CcSEcCtD
Amoxapine—ADRA1A—hindbrain—brain cancer	0.00249	0.0051	CbGeAlD
Amoxapine—Body temperature increased—Carboplatin—brain cancer	0.00247	0.00716	CcSEcCtD
Amoxapine—DRD2—hindbrain—brain cancer	0.00244	0.005	CbGeAlD
Amoxapine—Hallucination—Procarbazine—brain cancer	0.00243	0.00705	CcSEcCtD
Amoxapine—Vascular purpura—Temozolomide—brain cancer	0.00238	0.00692	CcSEcCtD
Amoxapine—Decreased appetite—Lomustine—brain cancer	0.00237	0.00689	CcSEcCtD
Amoxapine—DRD1—brainstem—brain cancer	0.00236	0.00485	CbGeAlD
Amoxapine—Nasal congestion—Temozolomide—brain cancer	0.00234	0.0068	CcSEcCtD
Amoxapine—Pancreatitis—Hydroxyurea—brain cancer	0.00231	0.00672	CcSEcCtD
Amoxapine—HTR3A—brainstem—brain cancer	0.00228	0.00469	CbGeAlD
Amoxapine—Purpura—Temozolomide—brain cancer	0.00221	0.00642	CcSEcCtD
Amoxapine—Body temperature increased—Lomustine—brain cancer	0.00216	0.00627	CcSEcCtD
Amoxapine—Alopecia—Procarbazine—brain cancer	0.00216	0.00626	CcSEcCtD
Amoxapine—Weight increased—Hydroxyurea—brain cancer	0.00215	0.00623	CcSEcCtD
Amoxapine—HTR2A—ganglion—brain cancer	0.00212	0.00435	CbGeAlD
Amoxapine—Drowsiness—Hydroxyurea—brain cancer	0.0021	0.00611	CcSEcCtD
Amoxapine—DRD1—telencephalon—brain cancer	0.0021	0.00431	CbGeAlD
Amoxapine—Tension—Procarbazine—brain cancer	0.00208	0.00605	CcSEcCtD
Amoxapine—Ataxia—Carmustine—brain cancer	0.00207	0.00602	CcSEcCtD
Amoxapine—Nervousness—Procarbazine—brain cancer	0.00206	0.00599	CcSEcCtD
Amoxapine—Stomatitis—Hydroxyurea—brain cancer	0.00205	0.00595	CcSEcCtD
Amoxapine—HTR3A—telencephalon—brain cancer	0.00203	0.00416	CbGeAlD
Amoxapine—Ataxia—Temozolomide—brain cancer	0.002	0.00582	CcSEcCtD
Amoxapine—Tremor—Procarbazine—brain cancer	0.00199	0.00578	CcSEcCtD
Amoxapine—HTR1B—brainstem—brain cancer	0.00192	0.00393	CbGeAlD
Amoxapine—GABRA1—brainstem—brain cancer	0.00192	0.00393	CbGeAlD
Amoxapine—Olanzapine—CYP2C9—brain cancer	0.00191	0.183	CrCbGaD
Amoxapine—Syncope—Procarbazine—brain cancer	0.0019	0.00553	CcSEcCtD
Amoxapine—Leukopenia—Procarbazine—brain cancer	0.0019	0.00552	CcSEcCtD
Amoxapine—SLC6A3—brainstem—brain cancer	0.0019	0.0039	CbGeAlD
Amoxapine—DRD4—brain—brain cancer	0.00188	0.00386	CbGeAlD
Amoxapine—Hallucination—Hydroxyurea—brain cancer	0.00188	0.00545	CcSEcCtD
Amoxapine—Loss of consciousness—Procarbazine—brain cancer	0.00187	0.00542	CcSEcCtD
Amoxapine—Convulsion—Procarbazine—brain cancer	0.00184	0.00534	CcSEcCtD
Amoxapine—HTR2C—brainstem—brain cancer	0.00184	0.00377	CbGeAlD
Amoxapine—Hypertension—Procarbazine—brain cancer	0.00183	0.00532	CcSEcCtD
Amoxapine—HTR2A—endothelium—brain cancer	0.00183	0.00375	CbGeAlD
Amoxapine—DRD3—head—brain cancer	0.00182	0.00374	CbGeAlD
Amoxapine—Dry mouth—Procarbazine—brain cancer	0.00177	0.00513	CcSEcCtD
Amoxapine—HTR6—head—brain cancer	0.00176	0.0036	CbGeAlD
Amoxapine—Confusional state—Procarbazine—brain cancer	0.00175	0.00507	CcSEcCtD
Amoxapine—SLC6A4—brainstem—brain cancer	0.00174	0.00357	CbGeAlD
Amoxapine—Vomiting—Lomustine—brain cancer	0.00174	0.00504	CcSEcCtD
Amoxapine—Oedema—Procarbazine—brain cancer	0.00173	0.00503	CcSEcCtD
Amoxapine—Shock—Procarbazine—brain cancer	0.00171	0.00495	CcSEcCtD
Amoxapine—Pollakiuria—Temozolomide—brain cancer	0.0017	0.00494	CcSEcCtD
Amoxapine—HTR1B—telencephalon—brain cancer	0.0017	0.00349	CbGeAlD
Amoxapine—GABRA1—telencephalon—brain cancer	0.0017	0.00349	CbGeAlD
Amoxapine—Erectile dysfunction—Temozolomide—brain cancer	0.0017	0.00493	CcSEcCtD
Amoxapine—Thrombocytopenia—Procarbazine—brain cancer	0.0017	0.00493	CcSEcCtD
Amoxapine—Tachycardia—Procarbazine—brain cancer	0.00169	0.00491	CcSEcCtD
Amoxapine—SLC6A3—telencephalon—brain cancer	0.00169	0.00346	CbGeAlD
Amoxapine—HTR2A—blood vessel—brain cancer	0.00168	0.00346	CbGeAlD
Amoxapine—Weight increased—Temozolomide—brain cancer	0.00168	0.00487	CcSEcCtD
Amoxapine—Alopecia—Hydroxyurea—brain cancer	0.00167	0.00484	CcSEcCtD
Amoxapine—DRD3—central nervous system—brain cancer	0.00167	0.00342	CbGeAlD
Amoxapine—Stomatitis—Carmustine—brain cancer	0.00166	0.00481	CcSEcCtD
Amoxapine—Anorexia—Procarbazine—brain cancer	0.00165	0.0048	CcSEcCtD
Amoxapine—HTR2C—telencephalon—brain cancer	0.00163	0.00334	CbGeAlD
Amoxapine—Nausea—Lomustine—brain cancer	0.00162	0.00471	CcSEcCtD
Amoxapine—Hypotension—Procarbazine—brain cancer	0.00162	0.0047	CcSEcCtD
Amoxapine—HTR2A—hindbrain—brain cancer	0.00161	0.0033	CbGeAlD
Amoxapine—HTR6—central nervous system—brain cancer	0.0016	0.00329	CbGeAlD
Amoxapine—Stomatitis—Temozolomide—brain cancer	0.0016	0.00465	CcSEcCtD
Amoxapine—Insomnia—Procarbazine—brain cancer	0.00157	0.00455	CcSEcCtD
Amoxapine—Paraesthesia—Procarbazine—brain cancer	0.00156	0.00452	CcSEcCtD
Amoxapine—HTR1A—brainstem—brain cancer	0.00155	0.00317	CbGeAlD
Amoxapine—SLC6A4—telencephalon—brain cancer	0.00154	0.00317	CbGeAlD
Amoxapine—Somnolence—Procarbazine—brain cancer	0.00154	0.00447	CcSEcCtD
Amoxapine—CHRM1—telencephalon—brain cancer	0.00154	0.00316	CbGeAlD
Amoxapine—SLC6A2—brainstem—brain cancer	0.00153	0.00315	CbGeAlD
Amoxapine—HTR2B—telencephalon—brain cancer	0.00153	0.00314	CbGeAlD
Amoxapine—Hallucination—Carmustine—brain cancer	0.00152	0.00441	CcSEcCtD
Amoxapine—Hypoaesthesia—Carmustine—brain cancer	0.00152	0.00441	CcSEcCtD
Amoxapine—Decreased appetite—Procarbazine—brain cancer	0.00151	0.00437	CcSEcCtD
Amoxapine—DRD1—midbrain—brain cancer	0.00151	0.00309	CbGeAlD
Amoxapine—Fatigue—Procarbazine—brain cancer	0.00149	0.00434	CcSEcCtD
Amoxapine—Constipation—Procarbazine—brain cancer	0.00148	0.0043	CcSEcCtD
Amoxapine—HTR7—brainstem—brain cancer	0.00148	0.00303	CbGeAlD
Amoxapine—Hepatitis—Temozolomide—brain cancer	0.00147	0.00428	CcSEcCtD
Amoxapine—Leukopenia—Hydroxyurea—brain cancer	0.00147	0.00427	CcSEcCtD
Amoxapine—Hallucination—Temozolomide—brain cancer	0.00147	0.00426	CcSEcCtD
Amoxapine—Hypoaesthesia—Temozolomide—brain cancer	0.00147	0.00426	CcSEcCtD
Amoxapine—CYP2D6—hindbrain—brain cancer	0.00146	0.003	CbGeAlD
Amoxapine—Feeling abnormal—Procarbazine—brain cancer	0.00143	0.00415	CcSEcCtD
Amoxapine—ADRA1A—brainstem—brain cancer	0.00142	0.00292	CbGeAlD
Amoxapine—Convulsion—Hydroxyurea—brain cancer	0.00142	0.00413	CcSEcCtD
Amoxapine—Gastrointestinal pain—Procarbazine—brain cancer	0.00142	0.00412	CcSEcCtD
Amoxapine—DRD2—brainstem—brain cancer	0.0014	0.00287	CbGeAlD
Amoxapine—Urticaria—Procarbazine—brain cancer	0.00138	0.004	CcSEcCtD
Amoxapine—Tinnitus—Temozolomide—brain cancer	0.00138	0.00399	CcSEcCtD
Amoxapine—HTR1A—telencephalon—brain cancer	0.00137	0.00282	CbGeAlD
Amoxapine—Abdominal pain—Procarbazine—brain cancer	0.00137	0.00398	CcSEcCtD
Amoxapine—Body temperature increased—Procarbazine—brain cancer	0.00137	0.00398	CcSEcCtD
Amoxapine—SLC6A2—telencephalon—brain cancer	0.00136	0.00279	CbGeAlD
Amoxapine—Alopecia—Carmustine—brain cancer	0.00135	0.00392	CcSEcCtD
Amoxapine—Oedema—Hydroxyurea—brain cancer	0.00134	0.00389	CcSEcCtD
Amoxapine—GABRA1—medulla oblongata—brain cancer	0.00134	0.00274	CbGeAlD
Amoxapine—DRD3—brain—brain cancer	0.00132	0.00271	CbGeAlD
Amoxapine—Thrombocytopenia—Hydroxyurea—brain cancer	0.00131	0.00381	CcSEcCtD
Amoxapine—HTR7—telencephalon—brain cancer	0.00131	0.00269	CbGeAlD
Amoxapine—DRD1—head—brain cancer	0.00131	0.00268	CbGeAlD
Amoxapine—Alopecia—Temozolomide—brain cancer	0.0013	0.00378	CcSEcCtD
Amoxapine—Acute coronary syndrome—Etoposide—brain cancer	0.0013	0.00376	CcSEcCtD
Amoxapine—Myocardial infarction—Etoposide—brain cancer	0.00129	0.00374	CcSEcCtD
Amoxapine—Stomatitis—Etoposide—brain cancer	0.00128	0.00372	CcSEcCtD
Amoxapine—Jaundice—Etoposide—brain cancer	0.00128	0.00372	CcSEcCtD
Amoxapine—HTR2C—medulla oblongata—brain cancer	0.00128	0.00263	CbGeAlD
Amoxapine—Anorexia—Hydroxyurea—brain cancer	0.00128	0.00371	CcSEcCtD
Amoxapine—HTR6—brain—brain cancer	0.00127	0.00261	CbGeAlD
Amoxapine—ORM1—spinal cord—brain cancer	0.00127	0.00261	CbGeAlD
Amoxapine—ADRA1A—telencephalon—brain cancer	0.00126	0.0026	CbGeAlD
Amoxapine—HTR3A—head—brain cancer	0.00126	0.00259	CbGeAlD
Amoxapine—Dysgeusia—Temozolomide—brain cancer	0.00126	0.00365	CcSEcCtD
Amoxapine—Vision blurred—Carmustine—brain cancer	0.00125	0.00364	CcSEcCtD
Amoxapine—Tremor—Carmustine—brain cancer	0.00124	0.00361	CcSEcCtD
Amoxapine—Asthenia—Procarbazine—brain cancer	0.00124	0.00361	CcSEcCtD
Amoxapine—DRD2—telencephalon—brain cancer	0.00124	0.00254	CbGeAlD
Amoxapine—Agranulocytosis—Etoposide—brain cancer	0.00123	0.00356	CcSEcCtD
Amoxapine—Pruritus—Procarbazine—brain cancer	0.00123	0.00356	CcSEcCtD
Amoxapine—Agitation—Carmustine—brain cancer	0.00122	0.00355	CcSEcCtD
Amoxapine—HTR1B—midbrain—brain cancer	0.00122	0.00251	CbGeAlD
Amoxapine—GABRA1—midbrain—brain cancer	0.00122	0.00251	CbGeAlD
Amoxapine—Temazepam—CYP2C9—brain cancer	0.00121	0.116	CrCbGaD
Amoxapine—SLC6A3—midbrain—brain cancer	0.00121	0.00248	CbGeAlD
Amoxapine—Vision blurred—Temozolomide—brain cancer	0.00121	0.00351	CcSEcCtD
Amoxapine—Tremor—Temozolomide—brain cancer	0.0012	0.00349	CcSEcCtD
Amoxapine—Somnolence—Hydroxyurea—brain cancer	0.00119	0.00346	CcSEcCtD
Amoxapine—DRD1—central nervous system—brain cancer	0.00119	0.00245	CbGeAlD
Amoxapine—HTR1B—spinal cord—brain cancer	0.00119	0.00244	CbGeAlD
Amoxapine—GABRA1—spinal cord—brain cancer	0.00119	0.00244	CbGeAlD
Amoxapine—Leukopenia—Carmustine—brain cancer	0.00119	0.00345	CcSEcCtD
Amoxapine—Diarrhoea—Procarbazine—brain cancer	0.00119	0.00344	CcSEcCtD
Amoxapine—SLC6A3—spinal cord—brain cancer	0.00118	0.00242	CbGeAlD
Amoxapine—Dyspepsia—Hydroxyurea—brain cancer	0.00118	0.00343	CcSEcCtD
Amoxapine—Agitation—Temozolomide—brain cancer	0.00118	0.00343	CcSEcCtD
Amoxapine—Hypoaesthesia—Etoposide—brain cancer	0.00117	0.00341	CcSEcCtD
Amoxapine—HTR2C—midbrain—brain cancer	0.00117	0.0024	CbGeAlD
Amoxapine—Decreased appetite—Hydroxyurea—brain cancer	0.00117	0.00339	CcSEcCtD
Amoxapine—Fatigue—Hydroxyurea—brain cancer	0.00116	0.00336	CcSEcCtD
Amoxapine—HTR3A—central nervous system—brain cancer	0.00115	0.00236	CbGeAlD
Amoxapine—Convulsion—Carmustine—brain cancer	0.00115	0.00334	CcSEcCtD
Amoxapine—Leukopenia—Temozolomide—brain cancer	0.00115	0.00334	CcSEcCtD
Amoxapine—Hypertension—Carmustine—brain cancer	0.00115	0.00333	CcSEcCtD
Amoxapine—Constipation—Hydroxyurea—brain cancer	0.00115	0.00333	CcSEcCtD
Amoxapine—Dizziness—Procarbazine—brain cancer	0.00115	0.00333	CcSEcCtD
Amoxapine—ORM1—endocrine gland—brain cancer	0.00114	0.00235	CbGeAlD
Amoxapine—HTR2C—spinal cord—brain cancer	0.00114	0.00234	CbGeAlD
Amoxapine—SLC6A2—gonad—brain cancer	0.00113	0.00233	CbGeAlD
Amoxapine—Palpitations—Temozolomide—brain cancer	0.00113	0.00329	CcSEcCtD
Amoxapine—Convulsion—Temozolomide—brain cancer	0.00111	0.00323	CcSEcCtD
Amoxapine—SLC6A4—midbrain—brain cancer	0.00111	0.00228	CbGeAlD
Amoxapine—Hypertension—Temozolomide—brain cancer	0.00111	0.00322	CcSEcCtD
Amoxapine—Feeling abnormal—Hydroxyurea—brain cancer	0.00111	0.00321	CcSEcCtD
Amoxapine—Vomiting—Procarbazine—brain cancer	0.0011	0.0032	CcSEcCtD
Amoxapine—HTR7—gonad—brain cancer	0.00109	0.00225	CbGeAlD
Amoxapine—Confusional state—Carmustine—brain cancer	0.00109	0.00317	CcSEcCtD
Amoxapine—Rash—Procarbazine—brain cancer	0.00109	0.00317	CcSEcCtD
Amoxapine—Dermatitis—Procarbazine—brain cancer	0.00109	0.00317	CcSEcCtD
Amoxapine—Headache—Procarbazine—brain cancer	0.00109	0.00315	CcSEcCtD
Amoxapine—Oedema—Carmustine—brain cancer	0.00108	0.00315	CcSEcCtD
Amoxapine—SLC6A4—spinal cord—brain cancer	0.00108	0.00222	CbGeAlD
Amoxapine—HTR1B—endocrine gland—brain cancer	0.00107	0.0022	CbGeAlD
Amoxapine—Dry mouth—Temozolomide—brain cancer	0.00107	0.0031	CcSEcCtD
Amoxapine—SLC6A2—medulla oblongata—brain cancer	0.00107	0.00219	CbGeAlD
Amoxapine—Thrombocytopenia—Carmustine—brain cancer	0.00106	0.00308	CcSEcCtD
Amoxapine—Body temperature increased—Hydroxyurea—brain cancer	0.00106	0.00308	CcSEcCtD
Amoxapine—HTR1B—head—brain cancer	0.00106	0.00217	CbGeAlD
Amoxapine—GABRA1—head—brain cancer	0.00106	0.00217	CbGeAlD
Amoxapine—Tachycardia—Carmustine—brain cancer	0.00106	0.00307	CcSEcCtD
Amoxapine—Confusional state—Temozolomide—brain cancer	0.00106	0.00307	CcSEcCtD
Amoxapine—SLC6A3—head—brain cancer	0.00105	0.00215	CbGeAlD
Amoxapine—Oedema—Temozolomide—brain cancer	0.00105	0.00304	CcSEcCtD
Amoxapine—Alopecia—Etoposide—brain cancer	0.00104	0.00303	CcSEcCtD
Amoxapine—Anorexia—Carmustine—brain cancer	0.00103	0.003	CcSEcCtD
Amoxapine—ORM1—central nervous system—brain cancer	0.00103	0.00211	CbGeAlD
Amoxapine—HTR7—medulla oblongata—brain cancer	0.00103	0.00211	CbGeAlD
Amoxapine—Nausea—Procarbazine—brain cancer	0.00103	0.00299	CcSEcCtD
Amoxapine—Thrombocytopenia—Temozolomide—brain cancer	0.00103	0.00298	CcSEcCtD
Amoxapine—HTR2C—head—brain cancer	0.00101	0.00208	CbGeAlD
Amoxapine—Hypotension—Carmustine—brain cancer	0.00101	0.00294	CcSEcCtD
Amoxapine—Diazepam—CYP2C9—brain cancer	0.00101	0.0965	CrCbGaD
Amoxapine—DRD2—pituitary gland—brain cancer	0.00101	0.00207	CbGeAlD
Amoxapine—Dysgeusia—Etoposide—brain cancer	0.00101	0.00292	CcSEcCtD
Amoxapine—Anorexia—Temozolomide—brain cancer	0.000999	0.0029	CcSEcCtD
Amoxapine—Clozapine—CYP2C9—brain cancer	0.000997	0.0953	CrCbGaD
Amoxapine—HTR1A—midbrain—brain cancer	0.000985	0.00202	CbGeAlD
Amoxapine—Insomnia—Carmustine—brain cancer	0.000981	0.00285	CcSEcCtD
Amoxapine—HRH1—telencephalon—brain cancer	0.000979	0.00201	CbGeAlD
Amoxapine—SLC6A4—endocrine gland—brain cancer	0.000974	0.002	CbGeAlD
Amoxapine—Paraesthesia—Carmustine—brain cancer	0.000974	0.00283	CcSEcCtD
Amoxapine—CHRM1—endocrine gland—brain cancer	0.000971	0.00199	CbGeAlD
Amoxapine—HTR1B—central nervous system—brain cancer	0.000966	0.00198	CbGeAlD
Amoxapine—GABRA1—central nervous system—brain cancer	0.000966	0.00198	CbGeAlD
Amoxapine—Somnolence—Carmustine—brain cancer	0.000964	0.0028	CcSEcCtD
Amoxapine—Asthenia—Hydroxyurea—brain cancer	0.000962	0.00279	CcSEcCtD
Amoxapine—SLC6A4—head—brain cancer	0.000962	0.00197	CbGeAlD
Amoxapine—ADRA2A—telencephalon—brain cancer	0.000961	0.00197	CbGeAlD
Amoxapine—HTR1A—spinal cord—brain cancer	0.000961	0.00197	CbGeAlD
Amoxapine—CHRM1—head—brain cancer	0.000958	0.00197	CbGeAlD
Amoxapine—SLC6A3—central nervous system—brain cancer	0.000958	0.00197	CbGeAlD
Amoxapine—HTR2B—head—brain cancer	0.000953	0.00196	CbGeAlD
Amoxapine—Insomnia—Temozolomide—brain cancer	0.000948	0.00275	CcSEcCtD
Amoxapine—DRD1—brain—brain cancer	0.000947	0.00194	CbGeAlD
Amoxapine—GABRA1—cerebellum—brain cancer	0.000944	0.00194	CbGeAlD
Amoxapine—Decreased appetite—Carmustine—brain cancer	0.000943	0.00274	CcSEcCtD
Amoxapine—HTR7—midbrain—brain cancer	0.000941	0.00193	CbGeAlD
Amoxapine—Paraesthesia—Temozolomide—brain cancer	0.000941	0.00273	CcSEcCtD
Amoxapine—SLC6A3—cerebellum—brain cancer	0.000936	0.00192	CbGeAlD
Amoxapine—Somnolence—Temozolomide—brain cancer	0.000932	0.00271	CcSEcCtD
Amoxapine—Constipation—Carmustine—brain cancer	0.000927	0.00269	CcSEcCtD
Amoxapine—HTR2C—central nervous system—brain cancer	0.000926	0.0019	CbGeAlD
Amoxapine—Dyspepsia—Temozolomide—brain cancer	0.000922	0.00268	CcSEcCtD
Amoxapine—HTR2A—brainstem—brain cancer	0.000921	0.00189	CbGeAlD
Amoxapine—Leukopenia—Etoposide—brain cancer	0.00092	0.00267	CcSEcCtD
Amoxapine—HTR7—spinal cord—brain cancer	0.000918	0.00188	CbGeAlD
Amoxapine—Diarrhoea—Hydroxyurea—brain cancer	0.000918	0.00266	CcSEcCtD
Amoxapine—HTR3A—brain—brain cancer	0.000914	0.00188	CbGeAlD
Amoxapine—Decreased appetite—Temozolomide—brain cancer	0.000911	0.00265	CcSEcCtD
Amoxapine—Fatigue—Temozolomide—brain cancer	0.000903	0.00262	CcSEcCtD
Amoxapine—Loss of consciousness—Etoposide—brain cancer	0.000903	0.00262	CcSEcCtD
Amoxapine—Constipation—Temozolomide—brain cancer	0.000896	0.0026	CcSEcCtD
Amoxapine—Feeling abnormal—Carmustine—brain cancer	0.000894	0.00259	CcSEcCtD
Amoxapine—Convulsion—Etoposide—brain cancer	0.00089	0.00258	CcSEcCtD
Amoxapine—DRD2—midbrain—brain cancer	0.00089	0.00183	CbGeAlD
Amoxapine—Hypertension—Etoposide—brain cancer	0.000887	0.00258	CcSEcCtD
Amoxapine—Dizziness—Hydroxyurea—brain cancer	0.000887	0.00258	CcSEcCtD
Amoxapine—Gastrointestinal pain—Carmustine—brain cancer	0.000887	0.00257	CcSEcCtD
Amoxapine—SLC6A4—central nervous system—brain cancer	0.000878	0.0018	CbGeAlD
Amoxapine—CHRM1—central nervous system—brain cancer	0.000875	0.0018	CbGeAlD
Amoxapine—HTR2B—central nervous system—brain cancer	0.00087	0.00179	CbGeAlD
Amoxapine—HTR1A—endocrine gland—brain cancer	0.000865	0.00178	CbGeAlD
Amoxapine—Feeling abnormal—Temozolomide—brain cancer	0.000863	0.00251	CcSEcCtD
Amoxapine—SLC6A2—endocrine gland—brain cancer	0.000858	0.00176	CbGeAlD
Amoxapine—Body temperature increased—Carmustine—brain cancer	0.000857	0.00249	CcSEcCtD
Amoxapine—Abdominal pain—Carmustine—brain cancer	0.000857	0.00249	CcSEcCtD
Amoxapine—Gastrointestinal pain—Temozolomide—brain cancer	0.000857	0.00249	CcSEcCtD
Amoxapine—HTR1A—head—brain cancer	0.000854	0.00175	CbGeAlD
Amoxapine—Vomiting—Hydroxyurea—brain cancer	0.000853	0.00248	CcSEcCtD
Amoxapine—SLC6A2—head—brain cancer	0.000847	0.00174	CbGeAlD
Amoxapine—Rash—Hydroxyurea—brain cancer	0.000846	0.00246	CcSEcCtD
Amoxapine—Confusional state—Etoposide—brain cancer	0.000845	0.00246	CcSEcCtD
Amoxapine—Dermatitis—Hydroxyurea—brain cancer	0.000845	0.00245	CcSEcCtD
Amoxapine—Headache—Hydroxyurea—brain cancer	0.00084	0.00244	CcSEcCtD
Amoxapine—CYP2D6—brainstem—brain cancer	0.000839	0.00172	CbGeAlD
Amoxapine—Urticaria—Temozolomide—brain cancer	0.000832	0.00242	CcSEcCtD
Amoxapine—Body temperature increased—Temozolomide—brain cancer	0.000828	0.00241	CcSEcCtD
Amoxapine—Abdominal pain—Temozolomide—brain cancer	0.000828	0.00241	CcSEcCtD
Amoxapine—HTR7—endocrine gland—brain cancer	0.000827	0.0017	CbGeAlD
Amoxapine—Thrombocytopenia—Etoposide—brain cancer	0.000821	0.00238	CcSEcCtD
Amoxapine—Tachycardia—Etoposide—brain cancer	0.000818	0.00238	CcSEcCtD
Amoxapine—HTR2A—telencephalon—brain cancer	0.000817	0.00168	CbGeAlD
Amoxapine—HTR7—head—brain cancer	0.000816	0.00168	CbGeAlD
Amoxapine—ADRA2A—gonad—brain cancer	0.000802	0.00165	CbGeAlD
Amoxapine—Anorexia—Etoposide—brain cancer	0.000799	0.00232	CcSEcCtD
Amoxapine—ADRA1A—endocrine gland—brain cancer	0.000797	0.00164	CbGeAlD
Amoxapine—Nausea—Hydroxyurea—brain cancer	0.000797	0.00231	CcSEcCtD
Amoxapine—ADRA1A—head—brain cancer	0.000787	0.00162	CbGeAlD
Amoxapine—Hypotension—Etoposide—brain cancer	0.000783	0.00228	CcSEcCtD
Amoxapine—ADRA2A—pituitary gland—brain cancer	0.000783	0.00161	CbGeAlD
Amoxapine—DRD2—endocrine gland—brain cancer	0.000782	0.0016	CbGeAlD
Amoxapine—HTR1A—central nervous system—brain cancer	0.00078	0.0016	CbGeAlD
Amoxapine—Asthenia—Carmustine—brain cancer	0.000778	0.00226	CcSEcCtD
Amoxapine—SLC6A2—central nervous system—brain cancer	0.000773	0.00159	CbGeAlD
Amoxapine—DRD2—head—brain cancer	0.000772	0.00158	CbGeAlD
Amoxapine—HTR1B—brain—brain cancer	0.000767	0.00157	CbGeAlD
Amoxapine—GABRA1—brain—brain cancer	0.000767	0.00157	CbGeAlD
Amoxapine—HTR1A—cerebellum—brain cancer	0.000762	0.00156	CbGeAlD
Amoxapine—SLC6A3—brain—brain cancer	0.000761	0.00156	CbGeAlD
Amoxapine—ADRA2A—medulla oblongata—brain cancer	0.000755	0.00155	CbGeAlD
Amoxapine—Paraesthesia—Etoposide—brain cancer	0.000753	0.00219	CcSEcCtD
Amoxapine—Asthenia—Temozolomide—brain cancer	0.000752	0.00218	CcSEcCtD
Amoxapine—Somnolence—Etoposide—brain cancer	0.000745	0.00216	CcSEcCtD
Amoxapine—HTR7—central nervous system—brain cancer	0.000745	0.00153	CbGeAlD
Amoxapine—CYP2D6—telencephalon—brain cancer	0.000745	0.00153	CbGeAlD
Amoxapine—Diarrhoea—Carmustine—brain cancer	0.000742	0.00215	CcSEcCtD
Amoxapine—Pruritus—Temozolomide—brain cancer	0.000741	0.00215	CcSEcCtD
Amoxapine—HTR2C—brain—brain cancer	0.000735	0.00151	CbGeAlD
Amoxapine—Decreased appetite—Etoposide—brain cancer	0.000729	0.00212	CcSEcCtD
Amoxapine—HTR7—cerebellum—brain cancer	0.000728	0.00149	CbGeAlD
Amoxapine—Fatigue—Etoposide—brain cancer	0.000723	0.0021	CcSEcCtD
Amoxapine—ADRA1A—central nervous system—brain cancer	0.000719	0.00147	CbGeAlD
Amoxapine—Dizziness—Carmustine—brain cancer	0.000717	0.00208	CcSEcCtD
Amoxapine—Constipation—Etoposide—brain cancer	0.000717	0.00208	CcSEcCtD
Amoxapine—Diarrhoea—Temozolomide—brain cancer	0.000717	0.00208	CcSEcCtD
Amoxapine—DRD2—central nervous system—brain cancer	0.000704	0.00145	CbGeAlD
Amoxapine—ADRA1A—cerebellum—brain cancer	0.000702	0.00144	CbGeAlD
Amoxapine—SLC6A4—brain—brain cancer	0.000697	0.00143	CbGeAlD
Amoxapine—CHRM1—brain—brain cancer	0.000694	0.00143	CbGeAlD
Amoxapine—Dizziness—Temozolomide—brain cancer	0.000693	0.00201	CcSEcCtD
Amoxapine—Feeling abnormal—Etoposide—brain cancer	0.000691	0.00201	CcSEcCtD
Amoxapine—HTR2B—brain—brain cancer	0.000691	0.00142	CbGeAlD
Amoxapine—ADRA2A—midbrain—brain cancer	0.00069	0.00142	CbGeAlD
Amoxapine—Vomiting—Carmustine—brain cancer	0.000689	0.002	CcSEcCtD
Amoxapine—DRD2—cerebellum—brain cancer	0.000688	0.00141	CbGeAlD
Amoxapine—Gastrointestinal pain—Etoposide—brain cancer	0.000686	0.00199	CcSEcCtD
Amoxapine—Rash—Carmustine—brain cancer	0.000684	0.00199	CcSEcCtD
Amoxapine—Dermatitis—Carmustine—brain cancer	0.000683	0.00198	CcSEcCtD
Amoxapine—HTR2A—gonad—brain cancer	0.000682	0.0014	CbGeAlD
Amoxapine—Headache—Carmustine—brain cancer	0.000679	0.00197	CcSEcCtD
Amoxapine—ADRA2A—spinal cord—brain cancer	0.000674	0.00138	CbGeAlD
Amoxapine—Vomiting—Temozolomide—brain cancer	0.000666	0.00193	CcSEcCtD
Amoxapine—Urticaria—Etoposide—brain cancer	0.000666	0.00193	CcSEcCtD
Amoxapine—HTR2A—pituitary gland—brain cancer	0.000666	0.00137	CbGeAlD
Amoxapine—Body temperature increased—Etoposide—brain cancer	0.000663	0.00192	CcSEcCtD
Amoxapine—Abdominal pain—Etoposide—brain cancer	0.000663	0.00192	CcSEcCtD
Amoxapine—Rash—Temozolomide—brain cancer	0.000661	0.00192	CcSEcCtD
Amoxapine—Dermatitis—Temozolomide—brain cancer	0.00066	0.00192	CcSEcCtD
Amoxapine—Headache—Temozolomide—brain cancer	0.000656	0.00191	CcSEcCtD
Amoxapine—Nausea—Carmustine—brain cancer	0.000644	0.00187	CcSEcCtD
Amoxapine—HTR2A—medulla oblongata—brain cancer	0.000642	0.00132	CbGeAlD
Amoxapine—Nausea—Temozolomide—brain cancer	0.000622	0.00181	CcSEcCtD
Amoxapine—HTR1A—brain—brain cancer	0.000619	0.00127	CbGeAlD
Amoxapine—HRH1—endocrine gland—brain cancer	0.000617	0.00127	CbGeAlD
Amoxapine—SLC6A2—brain—brain cancer	0.000614	0.00126	CbGeAlD
Amoxapine—HRH1—head—brain cancer	0.000609	0.00125	CbGeAlD
Amoxapine—ADRA2A—endocrine gland—brain cancer	0.000606	0.00124	CbGeAlD
Amoxapine—Asthenia—Etoposide—brain cancer	0.000602	0.00175	CcSEcCtD
Amoxapine—ADRA2A—head—brain cancer	0.000599	0.00123	CbGeAlD
Amoxapine—Pruritus—Etoposide—brain cancer	0.000593	0.00172	CcSEcCtD
Amoxapine—HTR7—brain—brain cancer	0.000591	0.00121	CbGeAlD
Amoxapine—HTR2A—midbrain—brain cancer	0.000587	0.0012	CbGeAlD
Amoxapine—Diarrhoea—Etoposide—brain cancer	0.000574	0.00167	CcSEcCtD
Amoxapine—HTR2A—spinal cord—brain cancer	0.000573	0.00118	CbGeAlD
Amoxapine—ADRA1A—brain—brain cancer	0.000571	0.00117	CbGeAlD
Amoxapine—DRD2—brain—brain cancer	0.000559	0.00115	CbGeAlD
Amoxapine—HRH1—central nervous system—brain cancer	0.000556	0.00114	CbGeAlD
Amoxapine—Dizziness—Etoposide—brain cancer	0.000554	0.00161	CcSEcCtD
Amoxapine—ADRA2A—central nervous system—brain cancer	0.000546	0.00112	CbGeAlD
Amoxapine—ADRA2A—cerebellum—brain cancer	0.000534	0.0011	CbGeAlD
Amoxapine—Vomiting—Etoposide—brain cancer	0.000533	0.00155	CcSEcCtD
Amoxapine—Rash—Etoposide—brain cancer	0.000529	0.00154	CcSEcCtD
Amoxapine—Dermatitis—Etoposide—brain cancer	0.000528	0.00153	CcSEcCtD
Amoxapine—Headache—Etoposide—brain cancer	0.000525	0.00153	CcSEcCtD
Amoxapine—HTR2A—endocrine gland—brain cancer	0.000516	0.00106	CbGeAlD
Amoxapine—HTR2A—head—brain cancer	0.000509	0.00104	CbGeAlD
Amoxapine—Nausea—Etoposide—brain cancer	0.000498	0.00145	CcSEcCtD
Amoxapine—CYP2D6—endocrine gland—brain cancer	0.00047	0.000964	CbGeAlD
Amoxapine—HTR2A—central nervous system—brain cancer	0.000465	0.000954	CbGeAlD
Amoxapine—CYP2D6—head—brain cancer	0.000464	0.000952	CbGeAlD
Amoxapine—HTR2A—cerebellum—brain cancer	0.000454	0.000932	CbGeAlD
Amoxapine—HRH1—brain—brain cancer	0.000442	0.000906	CbGeAlD
Amoxapine—ADRA2A—brain—brain cancer	0.000434	0.00089	CbGeAlD
Amoxapine—CYP2D6—central nervous system—brain cancer	0.000423	0.000869	CbGeAlD
Amoxapine—CYP2D6—cerebellum—brain cancer	0.000414	0.000849	CbGeAlD
Amoxapine—HTR2A—brain—brain cancer	0.000369	0.000757	CbGeAlD
Amoxapine—CYP2D6—brain—brain cancer	0.000336	0.00069	CbGeAlD
Amoxapine—CYP2D6—Metabolism—ENO2—brain cancer	2.75e-05	0.0002	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VAV1—brain cancer	2.74e-05	0.0002	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	2.74e-05	0.000199	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IRS2—brain cancer	2.71e-05	0.000197	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—PIK3CG—brain cancer	2.7e-05	0.000197	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—APC—brain cancer	2.7e-05	0.000197	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—IL2—brain cancer	2.7e-05	0.000196	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—IL2—brain cancer	2.68e-05	0.000195	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IRS2—brain cancer	2.67e-05	0.000195	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	2.67e-05	0.000194	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—APC—brain cancer	2.66e-05	0.000193	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—PIK3CG—brain cancer	2.66e-05	0.000193	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PDGFRA—brain cancer	2.65e-05	0.000193	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	2.64e-05	0.000192	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SPP1—brain cancer	2.58e-05	0.000188	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—MYC—brain cancer	2.57e-05	0.000187	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SPP1—brain cancer	2.56e-05	0.000187	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VAV1—brain cancer	2.55e-05	0.000185	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—PIK3CG—brain cancer	2.54e-05	0.000185	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—APC—brain cancer	2.54e-05	0.000185	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—EGFR—brain cancer	2.53e-05	0.000184	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—EGFR—brain cancer	2.53e-05	0.000184	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—EGFR—brain cancer	2.52e-05	0.000183	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—EGFR—brain cancer	2.46e-05	0.000179	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL2—brain cancer	2.45e-05	0.000178	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HES1—brain cancer	2.45e-05	0.000178	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL2—brain cancer	2.44e-05	0.000178	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—EGFR—brain cancer	2.42e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HES1—brain cancer	2.41e-05	0.000175	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HES1—brain cancer	2.4e-05	0.000175	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HES1—brain cancer	2.39e-05	0.000174	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—PIK3CG—brain cancer	2.39e-05	0.000174	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—APC—brain cancer	2.39e-05	0.000174	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—IL2—brain cancer	2.37e-05	0.000173	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—APC—brain cancer	2.36e-05	0.000172	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—PIK3CG—brain cancer	2.36e-05	0.000172	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HES1—brain cancer	2.36e-05	0.000172	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—IL2—brain cancer	2.33e-05	0.00017	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PDGFRA—brain cancer	2.33e-05	0.00017	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IRS2—brain cancer	2.33e-05	0.00017	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—IL2—brain cancer	2.33e-05	0.000169	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—IL2—brain cancer	2.32e-05	0.000169	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IRS2—brain cancer	2.32e-05	0.000169	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—EGFR—brain cancer	2.31e-05	0.000168	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	2.29e-05	0.000167	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PDGFRA—brain cancer	2.29e-05	0.000167	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	2.28e-05	0.000166	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	2.28e-05	0.000166	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SPP1—brain cancer	2.26e-05	0.000165	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	2.24e-05	0.000163	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SPP1—brain cancer	2.23e-05	0.000162	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SPP1—brain cancer	2.22e-05	0.000162	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SPP1—brain cancer	2.21e-05	0.000161	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HES1—brain cancer	2.19e-05	0.000159	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—EGFR—brain cancer	2.18e-05	0.000159	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SPP1—brain cancer	2.18e-05	0.000159	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—RELA—brain cancer	2.17e-05	0.000158	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—RELA—brain cancer	2.17e-05	0.000158	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—ERBB2—brain cancer	2.16e-05	0.000157	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—ERBB2—brain cancer	2.16e-05	0.000157	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—TP53—brain cancer	2.16e-05	0.000157	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL2—brain cancer	2.15e-05	0.000157	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—EGFR—brain cancer	2.15e-05	0.000157	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	2.12e-05	0.000154	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL2—brain cancer	2.12e-05	0.000154	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL2—brain cancer	2.11e-05	0.000154	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—TP53—brain cancer	2.11e-05	0.000154	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—RELA—brain cancer	2.11e-05	0.000154	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL2—brain cancer	2.11e-05	0.000153	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—ERBB2—brain cancer	2.1e-05	0.000153	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	2.09e-05	0.000152	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—RELA—brain cancer	2.08e-05	0.000151	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL2—brain cancer	2.07e-05	0.000151	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—ERBB2—brain cancer	2.06e-05	0.00015	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—APC—brain cancer	2.06e-05	0.00015	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	2.06e-05	0.00015	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	2.05e-05	0.000149	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—APC—brain cancer	2.05e-05	0.000149	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IRS2—brain cancer	2.05e-05	0.000149	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SPP1—brain cancer	2.02e-05	0.000147	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IRS2—brain cancer	2.01e-05	0.000147	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IRS2—brain cancer	2.01e-05	0.000146	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IRS2—brain cancer	2e-05	0.000146	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—RELA—brain cancer	1.98e-05	0.000144	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.97e-05	0.000143	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—ERBB2—brain cancer	1.97e-05	0.000143	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL2—brain cancer	1.96e-05	0.000142	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL2—brain cancer	1.95e-05	0.000142	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PIK3CG—brain cancer	1.93e-05	0.000141	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.93e-05	0.00014	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CCND1—brain cancer	1.91e-05	0.000139	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CCND1—brain cancer	1.9e-05	0.000139	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL2—brain cancer	1.9e-05	0.000138	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CTNNB1—brain cancer	1.89e-05	0.000137	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CTNNB1—brain cancer	1.89e-05	0.000137	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.87e-05	0.000136	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL2—brain cancer	1.87e-05	0.000136	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—RELA—brain cancer	1.87e-05	0.000136	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.86e-05	0.000136	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—ERBB2—brain cancer	1.86e-05	0.000135	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CCND1—brain cancer	1.85e-05	0.000135	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—RELA—brain cancer	1.84e-05	0.000134	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CTNNB1—brain cancer	1.83e-05	0.000134	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—ERBB2—brain cancer	1.83e-05	0.000133	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.83e-05	0.000133	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CCND1—brain cancer	1.82e-05	0.000133	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—APC—brain cancer	1.81e-05	0.000132	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.81e-05	0.000132	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CTNNB1—brain cancer	1.81e-05	0.000131	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL2—brain cancer	1.79e-05	0.00013	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—APC—brain cancer	1.78e-05	0.000129	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.78e-05	0.000129	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—APC—brain cancer	1.77e-05	0.000129	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.77e-05	0.000129	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	1.77e-05	0.000129	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—APC—brain cancer	1.77e-05	0.000129	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CCND1—brain cancer	1.74e-05	0.000127	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—APC—brain cancer	1.74e-05	0.000127	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.74e-05	0.000127	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CTNNB1—brain cancer	1.72e-05	0.000125	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL2—brain cancer	1.68e-05	0.000123	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—VEGFA—brain cancer	1.66e-05	0.000121	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL2—brain cancer	1.66e-05	0.000121	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—VEGFA—brain cancer	1.66e-05	0.000121	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—STAT3—brain cancer	1.65e-05	0.00012	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—EGFR—brain cancer	1.65e-05	0.00012	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—STAT3—brain cancer	1.64e-05	0.00012	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CCND1—brain cancer	1.64e-05	0.000119	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CTNNB1—brain cancer	1.63e-05	0.000118	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CCND1—brain cancer	1.62e-05	0.000118	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—EGFR—brain cancer	1.62e-05	0.000118	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APC—brain cancer	1.62e-05	0.000118	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	1.62e-05	0.000118	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—EGFR—brain cancer	1.62e-05	0.000118	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—VEGFA—brain cancer	1.61e-05	0.000118	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—EGFR—brain cancer	1.61e-05	0.000117	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—RELA—brain cancer	1.61e-05	0.000117	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CTNNB1—brain cancer	1.6e-05	0.000117	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—RELA—brain cancer	1.6e-05	0.000116	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—STAT3—brain cancer	1.6e-05	0.000116	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—ERBB2—brain cancer	1.6e-05	0.000116	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—VEGFA—brain cancer	1.59e-05	0.000116	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—ERBB2—brain cancer	1.59e-05	0.000116	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	1.59e-05	0.000115	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—STAT3—brain cancer	1.57e-05	0.000115	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MYC—brain cancer	1.53e-05	0.000111	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MYC—brain cancer	1.53e-05	0.000111	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—VEGFA—brain cancer	1.52e-05	0.00011	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—STAT3—brain cancer	1.5e-05	0.000109	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—EGFR—brain cancer	1.5e-05	0.000109	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—EGFR—brain cancer	1.49e-05	0.000109	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MYC—brain cancer	1.49e-05	0.000108	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	1.47e-05	0.000107	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MYC—brain cancer	1.46e-05	0.000106	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—EGFR—brain cancer	1.45e-05	0.000106	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL2—brain cancer	1.45e-05	0.000105	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL2—brain cancer	1.44e-05	0.000105	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—VEGFA—brain cancer	1.43e-05	0.000104	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—EGFR—brain cancer	1.43e-05	0.000104	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—STAT3—brain cancer	1.42e-05	0.000103	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—VEGFA—brain cancer	1.41e-05	0.000103	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—RELA—brain cancer	1.41e-05	0.000103	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCND1—brain cancer	1.41e-05	0.000103	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCND1—brain cancer	1.4e-05	0.000102	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ERBB2—brain cancer	1.4e-05	0.000102	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—STAT3—brain cancer	1.4e-05	0.000102	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	1.4e-05	0.000102	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MYC—brain cancer	1.4e-05	0.000102	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	1.39e-05	0.000101	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RELA—brain cancer	1.39e-05	0.000101	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RELA—brain cancer	1.39e-05	0.000101	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RELA—brain cancer	1.38e-05	0.000101	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ERBB2—brain cancer	1.38e-05	0.0001	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ERBB2—brain cancer	1.38e-05	0.0001	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ERBB2—brain cancer	1.37e-05	9.99e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EGFR—brain cancer	1.37e-05	9.94e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RELA—brain cancer	1.36e-05	9.9e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	1.35e-05	9.84e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MYC—brain cancer	1.32e-05	9.58e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MYC—brain cancer	1.3e-05	9.46e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EGFR—brain cancer	1.29e-05	9.37e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2—brain cancer	1.27e-05	9.25e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EGFR—brain cancer	1.27e-05	9.25e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RELA—brain cancer	1.26e-05	9.2e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CG—brain cancer	1.26e-05	9.17e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—brain cancer	1.26e-05	9.14e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	1.26e-05	9.14e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—brain cancer	1.25e-05	9.13e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2—brain cancer	1.25e-05	9.11e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2—brain cancer	1.25e-05	9.09e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2—brain cancer	1.24e-05	9.06e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCND1—brain cancer	1.24e-05	9.02e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—brain cancer	1.23e-05	8.96e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CTNNB1—brain cancer	1.23e-05	8.93e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2—brain cancer	1.22e-05	8.92e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—brain cancer	1.22e-05	8.91e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—brain cancer	1.22e-05	8.89e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCND1—brain cancer	1.22e-05	8.88e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—STAT3—brain cancer	1.22e-05	8.87e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCND1—brain cancer	1.22e-05	8.86e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCND1—brain cancer	1.21e-05	8.83e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—STAT3—brain cancer	1.21e-05	8.82e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	1.21e-05	8.79e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CTNNB1—brain cancer	1.2e-05	8.77e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	1.2e-05	8.74e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—brain cancer	1.2e-05	8.74e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCND1—brain cancer	1.19e-05	8.69e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	1.18e-05	8.61e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—brain cancer	1.15e-05	8.35e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2—brain cancer	1.14e-05	8.28e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MYC—brain cancer	1.13e-05	8.24e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MYC—brain cancer	1.13e-05	8.2e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCND1—brain cancer	1.11e-05	8.08e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EGFR—brain cancer	1.11e-05	8.06e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EGFR—brain cancer	1.1e-05	8.02e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	1.1e-05	8e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—brain cancer	1.08e-05	7.87e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—brain cancer	1.08e-05	7.87e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—STAT3—brain cancer	1.07e-05	7.79e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—brain cancer	1.07e-05	7.77e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—brain cancer	1.06e-05	7.74e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—brain cancer	1.06e-05	7.72e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—brain cancer	1.06e-05	7.7e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—STAT3—brain cancer	1.05e-05	7.66e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—STAT3—brain cancer	1.05e-05	7.65e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—STAT3—brain cancer	1.05e-05	7.62e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	1.04e-05	7.58e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—STAT3—brain cancer	1.03e-05	7.5e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MYC—brain cancer	9.94e-06	7.24e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MYC—brain cancer	9.78e-06	7.12e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MYC—brain cancer	9.76e-06	7.1e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MYC—brain cancer	9.73e-06	7.08e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EGFR—brain cancer	9.72e-06	7.08e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	9.67e-06	7.04e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MYC—brain cancer	9.58e-06	6.97e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—STAT3—brain cancer	9.57e-06	6.97e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EGFR—brain cancer	9.56e-06	6.96e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EGFR—brain cancer	9.54e-06	6.95e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EGFR—brain cancer	9.51e-06	6.93e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EGFR—brain cancer	9.37e-06	6.82e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—brain cancer	9.3e-06	6.77e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—brain cancer	9.25e-06	6.73e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MYC—brain cancer	8.9e-06	6.48e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EGFR—brain cancer	8.7e-06	6.34e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—brain cancer	8.16e-06	5.94e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—brain cancer	8.03e-06	5.85e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—brain cancer	8.01e-06	5.83e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—brain cancer	7.99e-06	5.82e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—brain cancer	7.86e-06	5.73e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—brain cancer	7.31e-06	5.32e-05	CbGpPWpGaD
